Advances in penumbra imaging with MR

被引:18
作者
Davis, SM [1 ]
Donnan, GA
机构
[1] Royal Melbourne Hosp, Dept Neurol, Parkville, Vic 3050, Australia
[2] Austin & Repatriat Med Ctr, Natl Stroke Res Inst, Heidelberg, Vic, Australia
关键词
ischaemic stroke; magnetic resonance imaging; mismatch; penumbra; stroke outcome;
D O I
10.1159/000075301
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The concept of the ischaemic penumbra as critically hypoperfused and functionally impaired, but potentially viable brain, was introduced over 25 years ago. Recent studies have used a combination of perfusion-weighted magnetic resonance imaging (PWI) and diffusion-weighted imaging (DWI) to delineate the putative penumbra. PWI provides semiquantitative cerebral blood flow imaging and DWI is an index of the largely irreversible ischaemic core. PWI > DWI mismatch is an operational definition of the penumbra that was introduced in the late 1990s. This definition has been modified in recent years with the recognition that the PWI boundary includes a region of benign oligaemia and that a portion of the DWI core is potentially salvageable with rapid reperfusion. An MRI penumbral signature is present in the majority of patients within 6 h of stroke onset, often but not invariably associated with proximal arterial occlusion on magnetic resonance angiography, and is strictly time dependent. It has been postulated that penumbral imaging using MRI can provide a physiological 'tissue clock' and be used to predict benefit from thrombolytic therapy beyond the established 3-hour window. This has been suggested by pilot studies, but confirmation will rely on ongoing, prospective, randomized trials. The presence and extent of the penumbra may also predict the opportunity for tissue salvage with neuroprotection strategies. DWI and PWI parameters are being used in proof-of-principle stroke trials. Such trials can be performed with 100-200 patients randomized between treated and control groups and provide a biological signal of efficacy with only 10% of the sample size required for a Phase III study. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:23 / 27
页数:5
相关论文
共 29 条
[21]   Acute hyperglycemia adversely affects stroke outcome: A magnetic resonance imaging and spectroscopy study [J].
Parsons, MW ;
Barber, PA ;
Desmond, PM ;
Baird, TA ;
Darby, DG ;
Byrnes, G ;
Tress, BM ;
Davis, SM .
ANNALS OF NEUROLOGY, 2002, 52 (01) :20-28
[22]   Perfusion magnetic resonance imaging maps in hyperacute stroke - Relative cerebral blood flow most accurately identifies tissue destined to infarct [J].
Parsons, MW ;
Yang, Q ;
Barber, PA ;
Darby, DG ;
Desmond, PM ;
Gerraty, RP ;
Tress, BM ;
Davis, SM .
STROKE, 2001, 32 (07) :1581-1587
[23]   Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke [J].
Parsons, MW ;
Barber, PA ;
Chalk, J ;
Darby, DG ;
Rose, S ;
Desmond, PM ;
Gerraty, RP ;
Tress, BM ;
Wright, PM ;
Donnan, GA ;
Davis, SM .
ANNALS OF NEUROLOGY, 2002, 51 (01) :28-37
[24]  
Read SJ, 2000, ANN NEUROL, V48, P228, DOI 10.1002/1531-8249(200008)48:2<228::AID-ANA13>3.3.CO
[25]  
2-2
[26]   Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia the Glucose Insulin in Stroke Trial (GIST) [J].
Scott, JF ;
Robinson, GM ;
French, JM ;
O'Connell, JE ;
Alberti, KGMM ;
Gray, CS .
STROKE, 1999, 30 (04) :793-799
[27]  
Warach S, 2000, ANN NEUROL, V48, P713, DOI 10.1002/1531-8249(200011)48:5<713::AID-ANA4>3.3.CO
[28]  
2-R
[29]   Thrombolytic therapy with recombinant tissue plasminogen activator for acute ischemic stroke - Where do we go from here? A cumulative meta-analysis [J].
Wardlaw, JM ;
Sandercock, PAG ;
Berge, E .
STROKE, 2003, 34 (06) :1437-1442